Full text is available at the source.
Abstract
Seven FDA-approved anti-obesity medications may support long-term weight management.
- The medications include phentermine, orlistat, phentermine/topiramate ER, naltrexone SR/bupropion SR, liraglutide 3.0 mg, semaglutide 2.4 mg, and tirzepatide.
- Obesity is classified as a chronic disease, suggesting the need for sustained treatment.
- Data from phase 3 clinical trials contributed to the approval of these medications.
- The article reviews clinical indications, how each medication works, dosing, side effects, drug interactions, and contraindications.
Simplified